EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025

Daniel Evans iD, Henry Kunerth, Erica Mumm, Matthew Plumb, Laura Bohnker-Voels, Sarah Bistodeau, Scott A Cunningham, Jordan Davis, Karen Martin, Kathryn Como-Sabetti, Sarah Namugenyi, Xiong Wang und 3 weitere

Influenza and Other Respiratory Viruses · 2026

DOI: 10.1111/irv.70257 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Influenza and Other Respiratory Viruses, 2026. Verfasst von Daniel Evans und 14 weiteren Autor:innen. Beteiligte Einrichtung: Health Protection Bureau, Minnesota Department of Health, St. Paul, Minnesota, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Epidemiological Monitoring, Genome, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human respiratory syncytial virus (HRSV) imposes a substantial burden in the United States. The use of whole‐genome sequencing (WGS) for public health surveillance of HRSV lags that for other viral pathogens. The objective of this study was to expand the scope and depth of WGS‐based surveillance of HRSV in Minnesota, USA.

Methods

HRSV‐positive specimens collected from outpatients and inpatients from July 2023 to April 2025 were submitted to the Minnesota Public Health Laboratory for WGS. Genomes were sequenced using a tiled amplicon approach, characterized by lineage, phylogenetically compared to those from prior surveillance, and searched for mutations reported to affect monoclonal antibody susceptibility or fusion (F) protein function. Data from surveillance of HRSV‐associated hospitalizations were incorporated for epidemiological analysis.

Results

Continuing WGS through 2025 generated 2975 HRSV genomes. Compared to those from 2023 to 2024, genomes from the 2024–2025 season were collected from greater proportions of patients with HRSV‐associated hospitalizations, of older age, and from a broader geographical distribution. Subgroups A and B both exhibited significant differences in total genetic diversity by season ( p < 0.001). Twenty subclades and lineage A.D .5.4 were not observed during the 2024–2025 season. F protein mutations were identified at 15 amino acid positions of epidemiological concern, of which 11 emerged homoplastically. Genomes from 39 hospitalized patients carried at least one of these mutations.

Conclusions

Continuing WGS‐based HRSV surveillance across multiple respiratory seasons yielded valuable insights into the emergence and evolution of viral lineages and the prevalence of mutations of concern among outpatient and inpatient infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanEpidemiological MonitoringGenome, ViralMinnesotaWhole Genome SequencingPublic HealthHospitalizationMutationAntibodies, MonoclonalDrug Resistance, ViralSeasonsGenetic VariationViral Fusion ProteinsHumansMaleFemaleInfantChild, PreschoolChildAdolescentYoung AdultAdultMiddle Aged

Stichwörter der Autor:innen

epidemiological studieshuman respiratory syncytial virushumanized monoclonal antibodiesmolecular epidemiologymutational analysisorthopneumovirus

Substanzen

Antibodies, MonoclonalF protein, human respiratory syncytial virusViral Fusion ProteinsAntiviral Agents

Autor:innen und Institutionen

  • Health Protection Bureau, Minnesota Department of Health, St. Paul, Minnesota, USA.
  • Olmstead Medical Center, Rochester, Minnesota, USA.
  • Genomics Core, The Scripps Research Institute, La Jolla, California, USA.

ORCID-Profile: Daniel Evans

Förderung

  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Evans, D., Kunerth, H., Mumm, E., Plumb, M., Bohnker-Voels, L., Bistodeau, S., Cunningham, S. A., Davis, J., Martin, K., Como-Sabetti, K., Namugenyi, S., Wang, X., Lynfield, R., Strain, A., & Vetter, S. (2026). Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70257

Vancouver

Evans D, Kunerth H, Mumm E, Plumb M, Bohnker-Voels L, Bistodeau S, et al. Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025. Influenza and Other Respiratory Viruses. 2026. doi:10.1111/irv.70257

BibTeX
@article{Evans2026,
  author = {Evans, Daniel and Kunerth, Henry and Mumm, Erica and Plumb, Matthew and Bohnker-Voels, Laura and Bistodeau, Sarah and Cunningham, Scott A and Davis, Jordan and Martin, Karen and Como-Sabetti, Kathryn and Namugenyi, Sarah and Wang, Xiong and Lynfield, Ruth and Strain, Anna and Vetter, Sara},
  title = {Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2026},
  doi = {10.1111/irv.70257}
}
Kostenlos starten →